Screener
Nurix Therapeutics, Inc. NRIX License revenue — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | Three Months Ended May 31, 2026 | Three Months Ended May 31, 2025 | Six Months Ended May 31, 2026 | Six Months Ended May 31, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Collaboration revenue | $9,043 | $14,056 | $15,295 | $32,509 |
| License revenue | — | 30,000 | — | 30,000 |
| Total revenue | 9,043 | 44,056 | 15,295 | 62,509 |
| Operating expenses: | ||||
| Research and development | 87,653 | 78,096 | 171,789 | 147,759 |
| General and administrative | 15,594 | 14,282 | 30,205 | 25,936 |
| Total operating expenses | 103,247 | 92,378 | 201,994 | 173,695 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s license revenue — revenue?
- Nurix Therapeutics, Inc. (NRIX) reported license revenue — revenue of $0 in Q1 2026.
- How has Nurix Therapeutics, Inc.'s license revenue — revenue changed year-over-year?
- Nurix Therapeutics, Inc.'s license revenue — revenue decreased by 100.0% year-over-year, from $30M to $0.
- What does license revenue — revenue mean?
- This metric represents revenue generated from licensing intellectual property, technology platforms, or drug candidates to third-party partners. It reflects the company's ability to monetize its research and development pipeline through strategic collaborations and milestone payments. This revenue stream is a key indicator of the commercial validation of the company's proprietary drug discovery platform.
Ask your AI about Nurix Therapeutics, Inc.'s license revenue — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude